Adam S. Feldman, MD, MPH

Associate Professor of Surgery
Massachusetts General Hospital/Harvard Medical School

Dr. Adam S. Feldman is a Urologic Oncologist at the Massachusetts General Hospital Department of Urology. He is the co-Director of The Combined Harvard Medical School Urologic Oncology Fellowship Program and Director of Research for the Department of Urology at MGH. He completed his residency in urology in 2006 and subsequently completed his fellowship in urologic oncology in June 2008. Dr. Feldman focuses his clinical practice in the treatment of prostate cancer, bladder cancer, kidney cancer and other genitourinary malignancies. He focuses his research interests on translational and clinical research in prostate, bladder, and kidney cancers. He received a Prostate Cancer Foundation Young Investigator Award for his work in novel biomarkers in prostate cancer and was awarded a Physician Research Training Award by the Department of Defense. He has since received several federally funded, foundation and industry sponsored research grants for his work in biomarker development and metabolomics in genitourinary malignancies.

Disclosure information not submitted.

Presentation(s):

• 020IC - Trimodality Therapy for Management of Muscle Invasive Bladder Cancer

  Friday, May 13, 2022
  4:00 PM – 6:00 PM